Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pancreatic Cancer Treatment Market

Pancreatic Cancer Treatment Market Trends

Report ID: GMI9748
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Pancreatic Cancer Treatment Market Trends

The escalating incidence and prevalence of pancreatic cancer stands as a pivotal catalyst propelling the growth of the market.
Pancreatic cancer, characterized by its aggressive nature and often late-stage diagnosis, has witnessed a surge in cases globally.
For instance, globally, 458,918 new cases of pancreatic cancer have been reported in 2018, and 355,317 new cases are estimated to occur until 2040. The largest increase is expected in Asia, with a projected 88.8% rise in new cases from 2018 to 2040. Such high prevalence of pancreatic cancer cases will spur the demand for effective therapies, thus fostering the market growth.
Factors such as aging populations, lifestyle changes, and environmental factors contribute significantly to this rise. As the burden of pancreatic cancer continues to increase, the market for pancreatic cancer treatments is poised for substantial expansion in the coming years.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Industry size for pancreatic cancer treatment was USD 3 billion in 2023 and is projected to expand at 13.2% CAGR from 2024 to 2032, due to the increasing prevalence of pancreatic cancer across the globe.

The exocrine cancer type segment in the pancreatic cancer treatment industry accounted for USD 2.6 billion in 2023, due to the advancements in treatment options, such as surgery, chemotherapy, and targeted therapy.

The targeted therapy treatment type segment in the pancreatic cancer treatment industry accounted for 38.2% share in 2023 and is projected to grow at significant rate from 2024 to 2032, due to its precision and effectiveness in combating this challenging disease.

North America market recorded USD 1.2 billion in 2023, due to the presence of advanced healthcare infrastructure, high adoption of novel therapeutics, and a strong focus on R&D.